BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 32772279)

  • 1. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
    Bazeley P; Morales R; Tang WHW
    Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
    Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
    Yu X; Qian N; Wang Y
    Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
    J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View.
    Sikking MA; Stroeks SLVM; Waring OJ; Henkens MTHM; Riksen NP; Hoischen A; Heymans SRB; Verdonschot JAJ
    J Am Heart Assoc; 2023 Aug; 12(15):e030603. PubMed ID: 37489738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
    Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
    ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
    Marshall CH; Gondek LP; Luo J; Antonarakis ES
    Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of clonal hematopoiesis in heart failure.
    Chavkin NW; Min KD; Walsh K
    Trends Cardiovasc Med; 2022 May; 32(4):198-203. PubMed ID: 33892102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal Hematopoiesis and the Heart: a Toxic Relationship.
    Jensen JL; Easaw S; Anderson T; Varma Y; Zhang J; Jensen BC; Coombs CC
    Curr Oncol Rep; 2023 May; 25(5):455-463. PubMed ID: 36920637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
    Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
    Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease.
    Uddin MDM; Nguyen NQH; Yu B; Brody JA; Pampana A; Nakao T; Fornage M; Bressler J; Sotoodehnia N; Weinstock JS; Honigberg MC; Nachun D; Bhattacharya R; Griffin GK; Chander V; Gibbs RA; Rotter JI; Liu C; Baccarelli AA; Chasman DI; Whitsel EA; Kiel DP; Murabito JM; Boerwinkle E; Ebert BL; Jaiswal S; Floyd JS; Bick AG; Ballantyne CM; Psaty BM; Natarajan P; Conneely KN
    Nat Commun; 2022 Sep; 13(1):5350. PubMed ID: 36097025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.